
<DOC>
<DOCNO>WT02-B08-82</DOCNO>
<DOCOLDNO>IA072-000460-B045-116</DOCOLDNO>
<DOCHDR>
http://www.cinp.aust.com:80/thp.htm 203.108.64.146 19970121030809 text/html 8221
HTTP/1.0 200 OK
Date: Tue, 21 Jan 1997 02:59:10 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 8050
Last-modified: Tue, 18 Jun 1996 07:21:00 GMT
</DOCHDR>
<HTML>
<HEAD>
    <TITLE></TITLE>
</HEAD>
<BODY BGCOLOR="#e4f5ff">
<H5><CENTER><A HREF="index.htm#anchor689408"><IMG SRC="files.gif/smanlog.gif"
WIDTH="62" HEIGHT="57" ALIGN="BOTTOM" NATURALSIZEFLAG="3"></A></CENTER>
</H5>
<H5><BR>
<BR>
XX TH C.I.N.P. CONGRESS <BR>
WORLD CONGRESS CENTRE MELBOURNE </H5>
<HR>
<H2>THURSDAY JUNE 27, 1996 </H2>
<BR>
<HR><B>ROOM CODES: </B><BR>
LA = LA TROBE THEATRE, H2 = HOWQUA 2, H3 = HOWQUA 3, O1 = OTWAY 1, O2 =
OTWAY 2, C1 = CORRYONG<BR>
1, <BR>
C2-5 = CORRYONG 2-5, JB = JOHN BATMAN THEATRE, B1 = BELLARINE 1, B2 = BELLARINE
2, B3 =<BR>
BELLARINE 3, <BR>
B4 = BELLARINE 4, B5 = BELLARINE 5, B7 = BELLARINE 7 <BR>
<B><BR>
PRESENTATION CODES: </B><BR>
BW = BREAKFAST WORKSHOP, L = PLENARY LECTURE, P = POSTER PRESENTATION, <BR>
O = ORAL/FREE COMMUNICATION, S = SYMPOSIA <BR>
<BR>
<HR><B>DAY Thursday TIME 0730-0830 <BR>
<BR>
ROOM LA </B><BR>
<BR>
SESSION HEADING Breakfast Workshop <BR>
Supported by an Educational Grant from Sandoz Pharmaceuticals <BR>
<BR>
BW-4 
<BLOCKQUOTE>How to adequately treat therapy - resistant schizophrenia </BLOCKQUOTE>
<BR>
<HR><B>DAY Thursday TIME 1130-1230 <BR>
<BR>
ROOM JB </B><BR>
<BR>
SESSION HEADING Plenary Lecture <BR>
<BR>
L-4-1 Post, Robert M 
<BLOCKQUOTE>Mechanisms of Recurrance and Cyclicity in the Affective Disorders:
Implications for Treatment </BLOCKQUOTE>
<BR>
<HR><B>DAY Thursday TIME 1230-1330 <BR>
<BR>
ROOM JB </B><BR>
<BR>
SESSION HEADING Plenary Lecture <BR>
<BR>
L-5-1 Shine, John 
<BLOCKQUOTE>Genes in Mental Illness - Targets for Novel Therapies </BLOCKQUOTE>
<BR>
<HR><B>DAY Thursday TIME 0830-1100 <BR>
<BR>
ROOM C1 </B><BR>
<BR>
SESSION HEADING Neuroimaging <BR>
<BR>
O-23-1 Silberstein, Richard B 
<BLOCKQUOTE>Functional Brain Electrical Activity Mapping During the AX Version
of the Continuous Performance Task (CPT) inSchizophrenia </BLOCKQUOTE>
<BR>
O-23-2 Farrow, Maree A 
<BLOCKQUOTE>High Temporal Resolution FunctionalBrain Electrical Activity
Mapping in Attention Deficit Hyperactivity Disorder (ADHD) </BLOCKQUOTE>
<BR>
O-23-3 Saletu, Bernd 
<BLOCKQUOTE>Central Effects of 5HT1A-Agonists, S-20499 and Buspirone: Placebo-Controlled,
Pharmo-EEG and Psychometric Studies </BLOCKQUOTE>
<BR>
O-23-4 Winterer, Georg 
<BLOCKQUOTE>Quantitative EEG (QEEG) Predicts Relapse in Patients with Chronic
Alcoholism </BLOCKQUOTE>
<BR>
O-23-5 Le Poncin, Monique 
<BLOCKQUOTE>Spect Studies During Memorization Before and After Cognitive
Rehabiliation in Cerebral Diseases </BLOCKQUOTE>
<BR>
O-23-6 Kuhn, Karin 
<BLOCKQUOTE>Effects of the Releasing Hormones GHRH and CRH on the EEG in
Healthy Subjects </BLOCKQUOTE>
<BR>
O-23-7 Mager, Torsten 
<BLOCKQUOTE>D2 Dopamine Receptor Occupancy (IBZM-Spect) and Extrapyramidal
Symptoms Under Treatment With Risperidone </BLOCKQUOTE>
<BR>
O-23-8 Prentice, Neil 
<BLOCKQUOTE>A Study of Early and Late Onset Depression in the Elderly using
Spect </BLOCKQUOTE>
<BR>
O-23-9 Neumeister, Alexander 
<BLOCKQUOTE>HMPAO-Spect in Patients with Seasonal Affective Disorder Before
and After Light Therapy </BLOCKQUOTE>
<BR>
O-23-10 Trollor, Julian N 
<BLOCKQUOTE>A Spect Study of Alzheimer's Disease Using a Cognitive Activation
Paradigm </BLOCKQUOTE>
<BR>
<BR>
<HR><B>DAY Thursday TIME 1330-1600 <BR>
<BR>
ROOM O1 </B><BR>
<BR>
SESSION HEADING Heading to be decided <BR>
<BR>
O-24-1 Hranov, Luchezar G 
<BLOCKQUOTE>Type of Onset and Personality in Panic Disorder </BLOCKQUOTE>
<BR>
O-24-2 Judge, Rajinder 
<BLOCKQUOTE>Patient Disability in Panic Disorder </BLOCKQUOTE>
<BR>
O-24-3 Gabor, Pal S 
<BLOCKQUOTE>The Cerebral and Abdominal Forms of Panic Disorder and their
Differential Diagnosis </BLOCKQUOTE>
<BR>
O-24-4 Lucey, James V 
<BLOCKQUOTE>rCBF in Panic Disorder and Obsessive Compulsive Disorder </BLOCKQUOTE>
<BR>
O-24-5 Westenberg, Herman GM 
<BLOCKQUOTE>Developments in the Drug Treatment of Panic Disorder </BLOCKQUOTE>
<BR>
O-24-6 Strauss, Wolfgang H 
<BLOCKQUOTE>Combination of Pharmaco - and Psychotherapy in Panic Disorder
</BLOCKQUOTE>
<BR>
O-24-7 Koszycki, Diana 
<BLOCKQUOTE>The Effects of CCK-4 in Normal Individuals: Comparison of Panickers
and Nonpanickers </BLOCKQUOTE>
<BR>
O-24-8 Van Vliet, Irene M 
<BLOCKQUOTE>A Double-Blind Comparative Study of Fluvoxamine and Brofaromine
in Panic Disorder </BLOCKQUOTE>
<BR>
O-24-9 Judge, Rajinder 
<BLOCKQUOTE>The Long-Term Efficacy and Safety of Paroxetine in Panic Disorder
</BLOCKQUOTE>
<BR>
<BR>
<HR><B>DAY Thursday TIME 1330-1600 <BR>
<BR>
ROOM C1 </B><BR>
<BR>
SESSION HEADING Neuroendocrine <BR>
<BR>
O-25-1 Cleare, Anthony J 
<BLOCKQUOTE>5-HT Mediated Endocrine Responses to D-Fenfluramine in Hypothyroidism
Before and After Treatment </BLOCKQUOTE>
<BR>
O-25-2 Sargent, Peter A 
<BLOCKQUOTE>Effects of Nefazodone and Paroxetine on 5-Hydroxytryptamine
1A Receptor Sensitivity </BLOCKQUOTE>
<BR>
O-25-3 Hatzinger, Martin 
<BLOCKQUOTE>The Combined Dezamethasone/CRH-Test in Rats: Characterization
of the HPA Axis Activity in Aging </BLOCKQUOTE>
<BR>
O-25-4 Prange, Jr., Arthur J 
<BLOCKQUOTE>Thyroid Hormone Use in Euthyroid Patients in Medicine, Psychiatry,
and Surgery </BLOCKQUOTE>
<BR>
O-25-5 Franklin, Michael 
<BLOCKQUOTE>Effect of Dieting in Women and a Low Tryptophan Diet in Rats
on Prolactin Response to m-chlorophenylpiperazine </BLOCKQUOTE>
<BR>
O-25-6 Cooney, John M 
<BLOCKQUOTE>Fast Feedback: Evidence for the Functioning of Type II Steriod
Receptors in Depression </BLOCKQUOTE>
<BR>
O-25-7 Laakmann, Gregor 
<BLOCKQUOTE>Hormone and Catecholamine Secretion after Administration of
Moclobemide in Depressive In-Patients </BLOCKQUOTE>
<BR>
O-25-8 Sapronov, Nikolai S 
<BLOCKQUOTE>Adrenergic and Cholinergic Mechanisms in ACTH Glucocorticoids
Secretion </BLOCKQUOTE>
<BR>
O-25-9 Bersani, Guiseppe 
<BLOCKQUOTE>Neuroendocrine Correlates and Weight Gain During Treatment With
Clozapine </BLOCKQUOTE>
<BR>
O-25-10 Libiger, Jan 
<BLOCKQUOTE>Fenfluramine Challenge Test in Schizophrenia </BLOCKQUOTE>
<BR>
O-25-11 Burnett, Frances E 
<BLOCKQUOTE>The Effects of Naloxone on HPA Function in Depression </BLOCKQUOTE>
<BR>
<BR>
<HR><B>DAY Thursday TIME 1330-1600 <BR>
<BR>
ROOM C2 </B><BR>
<BR>
SESSION HEADING Depression: clinical <BR>
<BR>
O-26-1 Mitchell, Philip B 
<BLOCKQUOTE>Depressive Psychomotor Disturbance, Cortisol and Dexamethasone
</BLOCKQUOTE>
<BR>
O-26-2 Boyer, Patrice H 
<BLOCKQUOTE>Validation of the French Version of Prime-MD A Primary Care
Evaluation of Mental Disorder </BLOCKQUOTE>
<BR>
O-26-3 Herrmann, Werner M 
<BLOCKQUOTE>The Concept of Vigilance and Aspects of Thymoleptic Effects
in Depressive Disorder </BLOCKQUOTE>
<BR>
O-26-4 Van Hoof, Jacques J 
<BLOCKQUOTE>Psychomotor Slowing in Depression and Schizophrenia </BLOCKQUOTE>
<BR>
O-26-5 Janiri, Luigi 
<BLOCKQUOTE>Dysthymia: Psychpathological Profile and Treatment Correlates
</BLOCKQUOTE>
<BR>
O-26-6 Janiri, Luigi 
<BLOCKQUOTE>Comparison Between Self-Evaluation and Observer-Reported Scales
in a Sample of Dysthymic Patients </BLOCKQUOTE>
<BR>
O-26-7 Sarchiapone, Marco 
<BLOCKQUOTE>Response to Placebo in Dysthymic Disorder: Different Efficacy
on Depression and Anxiety </BLOCKQUOTE>
<BR>
O-26-8 Lecrubier, Yves 
<BLOCKQUOTE>Severe Depression: Recognition and Treatment </BLOCKQUOTE>
<BR>
<BR>
<HR><B>DAY ThursdayTIME 1330-1600 <BR>
<BR>
ROOM C3 </B><BR>
<BR>
SESSION HEADING Post mortem brain studies <BR>
<BR>
O-27-1 Marazziti, Donatella 
<BLOCKQUOTE>Localization and Characterization of Serotonin 2A Receptor in
Human Brain Postmortem </BLOCKQUOTE>
<BR>
O-27-2 Cooper, Stephen J 
<BLOCKQUOTE>CSF Amine Metabolites in Schizophrenia and Suicidal Behaviour
</BLOCKQUOTE>
<BR>
O-27-3 Becker, Udo 
<BLOCKQUOTE>Low cSF Serotonin (5-HT) and Suicidality </BLOCKQUOTE>
<BR>
O-27-4 Ozawa, Hiroki 
<BLOCKQUOTE>cAMP Signal Cascade in Postmortem Brains of Depressives and
Suicides </BLOCKQUOTE>
<BR>
O-27-5 Hall, Hakan 
<BLOCKQUOTE>Autoradiographic Localization of 5-HT1A-Receptors in the Human
Brain </BLOCKQUOTE>
<BR>
<HR>
<P><CENTER><A HREF="index.htm#anchor689408"><IMG SRC="files.gif/smanlog.gif"
WIDTH="62" HEIGHT="57" ALIGN="BOTTOM" NATURALSIZEFLAG="3"></A></CENTER>
</BODY>
</HTML>
</DOC>